Sanofi Historical Income Statement
| SNY Stock | USD 49.23 0.14 0.29% |
Historical analysis of Sanofi ADR income statement accounts such as Gross Profit of 21.8 B, Other Operating Expenses of 35.6 B, Operating Income of 8.7 B or Ebit of 8.7 B can show how well Sanofi ADR performed in making a profits. Evaluating Sanofi ADR income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Sanofi ADR's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Sanofi ADR latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Sanofi ADR is a good buy for the upcoming year.
Sanofi |
About Sanofi Income Statement Analysis
Sanofi ADR Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Sanofi ADR shareholders. The income statement also shows Sanofi investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Sanofi ADR Income Statement Chart
Sanofi ADR Income Statement is one of the three primary financial statements used for reporting Sanofi's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Sanofi ADR revenue and expense. Sanofi ADR Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Sanofi ADR's Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 1.1 B in 2024, whereas Total Revenue is likely to drop slightly above 31 B in 2024. Add Fundamental
Total Revenue
Total revenue comprises all receipts Sanofi ADR generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Sanofi ADR minus its cost of goods sold. It is profit before Sanofi ADR operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Sanofi ADR. It is also known as Sanofi ADR overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Net Income Applicable To Common Shares
The net income that remains after preferred dividends have been deducted, available to common shareholders.Most accounts from Sanofi ADR's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Sanofi ADR current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanofi ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.At this time, Sanofi ADR's Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 1.1 B in 2024, whereas Total Revenue is likely to drop slightly above 31 B in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 26.9B | 31.7B | 26.5B | 21.8B | Total Revenue | 39.2B | 45.4B | 43.1B | 31.0B |
Sanofi ADR income statement Correlations
Click cells to compare fundamentals
Sanofi ADR Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sanofi ADR income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 2.1B | 1.7B | 2.6B | (2.7B) | 3.8B | 4.0B | |
| Interest Expense | 444M | 390M | 368M | 221M | 1.1B | 1.1B | |
| Total Revenue | 37.6B | 37.4B | 39.2B | 45.4B | 43.1B | 31.0B | |
| Gross Profit | 25.7B | 25.2B | 26.9B | 31.7B | 26.5B | 21.8B | |
| Other Operating Expenses | 30.4B | 29.5B | 30.0B | 7.3B | 33.9B | 35.6B | |
| Operating Income | 7.7B | 8.1B | 8.1B | 16.8B | 9.2B | 8.7B | |
| Ebit | 7.7B | 8.1B | 8.1B | 16.8B | 9.2B | 8.7B | |
| Research Development | 6.0B | 5.5B | 5.7B | 6.7B | 6.7B | 4.9B | |
| Ebitda | 9.8B | 9.8B | 10.8B | 14.1B | 13.0B | 9.8B | |
| Cost Of Revenue | 12.0B | 12.2B | 12.3B | 13.7B | 16.6B | 9.3B | |
| Total Operating Expenses | 18.4B | 17.3B | 17.8B | 19.8B | 17.3B | 15.0B | |
| Income Before Tax | 2.8B | 13.8B | 7.8B | 10.5B | 7.2B | 5.6B | |
| Total Other Income Expense Net | (4.9B) | 5.7B | (328M) | (6.3B) | (2.0B) | (2.1B) | |
| Net Income | 2.8B | 12.3B | 6.2B | 8.4B | 5.4B | 4.6B | |
| Income Tax Expense | 139M | 1.8B | 1.6B | 2.0B | 1.6B | 1.2B | |
| Net Income Applicable To Common Shares | 2.8B | 12.3B | 6.2B | 8.4B | 9.6B | 5.9B | |
| Minority Interest | 174M | 146M | (56M) | (113M) | (36M) | (34.2M) | |
| Selling And Marketing Expenses | 10.1B | 9.9B | 9.9B | 9.4B | 10.8B | 9.7B | |
| Net Income From Continuing Ops | 2.9B | 12.4B | 6.3B | 6.8B | 5.4B | 6.3B | |
| Tax Provision | 139M | 1.8B | 1.6B | 1.5B | 1.6B | 1.3B | |
| Interest Income | 141M | 53M | 40M | 206M | 546M | 573.3M | |
| Net Interest Income | (303M) | (337M) | (328M) | (234M) | (639M) | (671.0M) | |
| Reconciled Depreciation | 7.5B | 3.7B | 1.6B | 2.1B | 4.8B | 3.1B |
Currently Active Assets on Macroaxis
When determining whether Sanofi ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanofi ADR's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanofi Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanofi Adr Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanofi ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Sanofi Stock analysis
When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stocks Directory Find actively traded stocks across global markets |
Is Sanofi ADR's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanofi ADR. If investors know Sanofi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanofi ADR listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Earnings Share 1.93 | Revenue Per Share 18.492 | Quarterly Revenue Growth 0.023 | Return On Assets 0.0454 |
The market value of Sanofi ADR is measured differently than its book value, which is the value of Sanofi that is recorded on the company's balance sheet. Investors also form their own opinion of Sanofi ADR's value that differs from its market value or its book value, called intrinsic value, which is Sanofi ADR's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanofi ADR's market value can be influenced by many factors that don't directly affect Sanofi ADR's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanofi ADR's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanofi ADR is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanofi ADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.